268 related articles for article (PubMed ID: 32769488)
1. Silencing novel long non-coding RNA FKBP9P1 represses malignant progression and inhibits PI3K/AKT signaling of head and neck squamous cell carcinoma in vitro.
Yang YF; Feng L; Shi Q; Ma HZ; He SZ; Hou LZ; Wang R; Fang JG
Chin Med J (Engl); 2020 Sep; 133(17):2037-2043. PubMed ID: 32769488
[TBL] [Abstract][Full Text] [Related]
2. Risk SNP-mediated LINC01614 upregulation drives head and neck squamous cell carcinoma progression via PI3K/AKT signaling pathway.
Hou Y; Zhou M; Li Y; Tian T; Sun X; Chen M; Xu W; Lu M
Mol Carcinog; 2022 Aug; 61(8):797-811. PubMed ID: 35687049
[TBL] [Abstract][Full Text] [Related]
3. Campothecin suppresses cell proliferation and migration in head and neck squamous cell carcinoma by blocking RAB27A-mediated phosphatidylinositol 3 kinase (PI3K)/protein kinase B (AKT) pathway.
Zhao Y; Wang Y; Zhao L; Qu L; Zheng JH
J Physiol Pharmacol; 2024 Apr; 75(2):205-213. PubMed ID: 38736267
[TBL] [Abstract][Full Text] [Related]
4. G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway.
Xu R; Xu R; Wang Y; Wang W; Jiang L; Gong S
Comput Math Methods Med; 2022; 2022():6881932. PubMed ID: 35116073
[TBL] [Abstract][Full Text] [Related]
5. DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Fujita S
Int J Oncol; 2019 Mar; 54(3):1021-1032. PubMed ID: 30569110
[TBL] [Abstract][Full Text] [Related]
6. Silencing of long non-coding RNA LINC00958 inhibits head and neck squamous cell carcinoma progression and AKT/mTOR signaling pathway by targeting miR-106a-5p.
Yang YF; Feng L; Shi Q; Wang LW; Hou LZ; Wang R; Fang JG
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8408-8417. PubMed ID: 32894548
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S
Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
Liu M; Gao X; Liu CL
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
[TBL] [Abstract][Full Text] [Related]
9. Long non‑coding RNA fer‑1‑like family member 4 serves as a tumor suppressor in laryngeal squamous cell carcinoma cells via regulating the AKT/ERK signaling pathway.
Jiao L; Liu S; Liu L; Hao P; Gong Z; Yan Z; Xiang Y
Mol Med Rep; 2020 Dec; 22(6):5304-5312. PubMed ID: 33174027
[TBL] [Abstract][Full Text] [Related]
10. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
Li B; Zhu J; Meng L
Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA FAM239A promotes tumor cell proliferation and migration by regulating tyrosine phosphatase Src homology 2 domain-containing phosphatase 2 in head and neck squamous cell carcinoma.
Li Y; Guo Y; Liu Z; Mou Y; Fang H; Yang Y; Zhao X; Zhang H; Song X
Arch Oral Biol; 2023 Mar; 147():105615. PubMed ID: 36630765
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of HPIP Inhibits the Proliferation and Invasion of Head-and-Neck Squamous Cell Carcinoma Cells by Regulating PI3K/Akt Signaling Pathway.
Chen Y; Zhao R; Zhao Q; Shao Y; Zhang S
Oncol Res; 2016; 24(3):153-60. PubMed ID: 27458096
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
Yuan J; Xu XJ; Lin Y; Chen QY; Sun WJ; Tang L; Liang QX
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):198-206. PubMed ID: 30657561
[TBL] [Abstract][Full Text] [Related]
14. Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K/AKT/mTOR signaling pathway.
Hu J; Li G; Liu Z; Ma H; Yuan W; Lu Z; Zhang D; Ling H; Zhang F; Liu Y; Liu C; Qiu Y
Mol Carcinog; 2023 May; 62(5):628-640. PubMed ID: 36727616
[TBL] [Abstract][Full Text] [Related]
15. [Biological function and clinical significance of long non-coding RNA
Dong YY; Zheng XW; Mijiti M; Tian R; Guo QB; Wu YY; Gao W; Wen SX
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Mar; 58(3):240-249. PubMed ID: 36878503
[No Abstract] [Full Text] [Related]
16. Unlocking the Therapeutic Potential of LncRNA
Liu FL; Zhang ZC; Zhou SL; Liu XL; Xu W
Discov Med; 2024 Mar; 36(182):546-558. PubMed ID: 38531795
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LINC00491 accelerates head and neck squamous cell carcinoma progression through regulating miR-508-3p/SATB1 axis and activating Wnt signaling pathway.
Cui D; Li Z; Wei C; Zhang Q; Xiao C
Cytokine; 2024 Mar; 175():156444. PubMed ID: 38150791
[TBL] [Abstract][Full Text] [Related]
18. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
